The effectiveness and safety of Jerry automated peritoneal dialysis machine for maintenance peritoneal dialysis patients: a multicenter, randomized, and two phase crossover trial
Hui-ping ZHAO,Shao-mei LI,Chang-ying XING,Hong JIANG,Zhan-zheng ZHAO,Ying-hong LIU,Li-xia LU,Hui-bin TAN,Hai-bin REN,Azhati JIAYINAXI,Jing XIAO,Xiao FU,Xiaoyan YAN,Mei WANG
DOI: https://doi.org/10.3969/j.issn.1671-4091.2017.03.002
2017-01-01
Abstract:Objective To evaluate the effectiveness and safety of Jerry automated peritoneal dialysis (APD) machine for maintenance peritoneal dialysis (PD) patients through a prospective,multicenter,randomized and controlled trial.Methods This study was carried out in 6 PD centers in China,and chronic renal failure patients treated with PD for more than 3 months were enrolled.Patients in the experimental group used JARI-APD-1A APD machine,and those in the control group used Baxter HomeChoice APD machine.The calculated sample size should be 84 patients.A multicenter,randomized,two phase crossover,opened,and positive control trial was designed,and each phase lasted for one day.The primary effectiveness indices included consistency between displayed value and measured value of single cycle drainage volume and single cycle infusion volume.The secondary effectiveness indices included accuracy of temperature control,toxin removal,and correction of electrolyte and acid-base imbalance.Results from Jerry APD machine were compared to those from Baxter APD machine by non-inferiority test.The safety indices included clinical symptoms,vital signs,and occurrence of machine malfunction.SAS 9.4 software was used to analyze the results.Results ①A total of 84 patients (47 males and 37 females,average age 45.33±11.34 years old) were enrolled in this study.The predominant primary disease was chronic glomerulonephritis,accounting for 50％ of the patients.The average dialysis duration was 37.70±27.67 months.②As for primary effectiveness indices,the consistency between displayed value and measured value of single cycle drainage volume was 97.62％ in experimental group,accurately controlling the single cycle drainage volume and not inferior to that (98.81％) in control group (Z=4.315,P＜0.001);the consistency between displayed value and measured value of single infusion volume reached the accuracy of volume control in both groups and showed no difference between the two groups by non-inferiority test (Z=9.456,P＜0.001).③As for secondary effectiveness indices,the measured temperature was consistent with the required accuracy in both groups,and experimental group was not inferior to control group in this index;the changes of blood urea,creatinine and electrolytes before and after the treatment also had no differences between the two groups.④As for safety indices,the presence of uncomfortable symptoms,adverse events,and vital sign changes had no differences between the two groups.No machine malfunction was seen in both groups.Conclusions The multicenter randomized,opened,and two phase crossover clinical trial showed that the Jerry APD machine conformed to the standards of primary effectiveness indices,secondary effectiveness indices,and safety indices.Jerry APD machine is not inferior to Baxter APD machine in the effectiveness and safety indices.